Blood-Based Biomarkers May Lead to Earlier Diagnosis of Parkinson's Disease, Van Andel Institute Study
1/22/2013 8:05:14 AM
Parkinson's disease (PD) is a progressive neurological condition. At present, it is usually diagnosed only when motor features are present. Hence, there is a need to develop objective and measurable biomarkers to improve PD diagnostics during its earlier stage, prior to its motor onset. In this pilot study, researchers identified and tested the first blood-based circulating microRNA (miRNA) biomarkers for PD.
comments powered by